Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 481–504 of 619 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Oral Supplement Clear all

Conditions: Aging Problems
Interventions: Sulforaphane, Placebo capsules; Dietary Supplement
Lead sponsor: Northern Arizona University; Other
Eligibility: 60 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Flagstaff, Arizona

Conditions: BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
Interventions: soy isoflavones, placebo, questionnaire administration, magnetic resonance imaging, biopsy, immunohistochemistry staining method, laboratory biomarker analysis, mammography; Dietary Supplement · Other · Procedure
Lead sponsor: University of Southern California; Other
Eligibility: 30 Years to 75 Years · Female only
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Malnutrition
Interventions: ONS QIP, ONS Standard Feeding; Other
Lead sponsor: Abbott Nutrition; Industry
Eligibility: 18 Years and older
Enrollment: 2,386 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 4
States / cities: Barrington, Illinois • Libertyville, Illinois • Oak Lawn, Illinois + 1 more

Conditions: Cardiovascular Risk Factor, Obesity
Interventions: High Intensity Interval Training, Essential Amino Acid, High intensity interval training and essential amino acid supplement; Other · Dietary Supplement
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 30 Years to 50 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Upper Respiratory Tract Infections Due to Influenza or Rhinovirus
Interventions: transfer factor, Placebo; Dietary Supplement
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 40 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Autism Spectrum Disorder, Autistic Disorder, Neurodevelopmental Disorder, Childhood Developmental Disorders, Pervasive
Interventions: Sulforaphane, Placebo; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 13 Years to 30 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Carrboro, North Carolina

Conditions: Exercise
Interventions: beetroot and anthocyanin, beetroot and placebo; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 21 Years to 35 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Other Endocrine/Nutritional/Metabolic Disorder
Interventions: Nutritional Supplement Blend; Dietary Supplement
Lead sponsor: Pharmanex; Industry
Eligibility: 30 Years to 70 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Austin, Texas • Logan, Utah

Conditions: Schizophrenia and Related Disorders, Mitochondrial Alteration, Cognitive Impairment
Interventions: MitoQ, Placebo; Drug
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 35 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: New Haven, Connecticut • Belmont, Massachusetts

Conditions: Community-Acquired Staphylococcus Aureus
Interventions: Routine Measures Group, Bleach Bath Group (Bleach plus routine measures); Procedure
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 3 Months to 18 Years
Enrollment: 987 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Health Adult Subjects, Healthy Participants
Interventions: LathMized TM NAD+ (LNAD+), Control (placebo); Dietary Supplement · Other
Lead sponsor: BioNADrx Holdings, Inc. Bryleos; Industry
Eligibility: 45 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Clonal Cytopenia of Undetermined Significance, Myelodysplastic Syndrome
Interventions: Nicotinamide Riboside, Pterostilbene; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Idiopathic Pulmonary Fibrosis
Interventions: EGCG 300 mg + Nintedanib, EGCG 300 mg + Pirfenidone, Placebo 2 capsules + Nintedanib or Pirfenidone, EGCG 600 mg + Nintedanib, EGCG 600 mg + Pirfenidone, Placebo 4 capsules + Nintedanib or Pirfenidone; Combination Product
Lead sponsor: Hal Chapman; Other
Eligibility: 40 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 7
States / cities: San Francisco, California • Boston, Massachusetts • Ann Arbor, Michigan + 4 more

Conditions: Locally Advanced Head and Neck Carcinoma
Interventions: Dietary Supplement, Quality-of-Life Assessment, Questionnaire Administration; Dietary Supplement · Other
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pancreatic Cancer, Malnutrition
Interventions: Ensure Max Protein; Dietary Supplement
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Docosohexaenoic Acid Supplementation of Mothers to
Interventions: Expecta 200 mg, Expecta 1 gram; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Up to 45 Years · Female only
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Hyperglycemia
Interventions: Sitagliptin, Placebo, Regular Human Insulin, Insulin glargine, Supplemental insulin (Insulin lispro), Supplemental insulin (Insulin aspart); Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Muscle Weakness
Interventions: mung bean protein, control biscuit; Dietary Supplement · Other
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Iron Deficiency, Iron Deficiency Anemia (IDA), Vitamin D Deficiency, Vitamin D Insufficiency, Low Energy Availability, Bone Density
Interventions: Iron and Vitamin D Deficiencies Correction; Dietary Supplement
Lead sponsor: Morehouse School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Knee Arthritis, Knee Osteoarthritis, Knee Pain Chronic, Knee Discomfort, Rheumatoid Arthritis, Knee Pain Swelling
Interventions: Gold Factor (Gold Nanoparticles, AuNPs), Placebo; Dietary Supplement
Lead sponsor: 4Life Research, LLC; Industry
Eligibility: 18 Years to 87 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cystinuria
Interventions: Alpha lipoic acid, Placebo; Dietary Supplement · Drug
Lead sponsor: Thomas Chi, MD; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obstructive Sleep Apnea
Interventions: Oral appliance, Oxygen, Oral appliance plus oxygen, No treatment; Device · Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years to 79 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer, HER-2 Positive Breast Cancer
Interventions: Resistant Potato Starch, Placebo control; Dietary Supplement
Lead sponsor: University of Vermont Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Overweight and Obesity, Eating Behavior
Interventions: Placebo, Bromocriptine-QR; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 35 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

Treatment Strategy to Enhance Nrf2 Signaling in Older Adults

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

Quality Improvement Program (QIP) to Reduce 30-Day Readmission in Malnourished Hospitalized Patients

Essential Amino Acids and High Intensity Interval Training

Efficacy of Transfer Factor to Prevent Upper Respiratory Tract Infections in Healthy Adults

Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder

The Effects of Dietary Nitric Oxide and Anthocyanins on Anaerobic Exercise Performance

Nutritional Supplement Impact on Metabolic Parameters

MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

Prevention of Recurrent Infections Caused by Community Acquired Staphylococcus Aureus (CA-SA) in Children

Renewal-NAD+: A Study of Oral NAD+ and Its Multi-omic Impact in a Healthy Cohort

Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)

Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy

Whipple Protein Study

DHA Supplementation for Lactating Mothers

Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery

Effect of Supplementary Dietary Protein (21g Per Day) on Lean Mass and Strength in Sedentary, Adult Vegetarians

Collegiate Athlete Study

Gold Factor on Knee Joint Health and Function

Lipoic Acid Supplement for Cystine Stone

Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea

Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer

Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM